Corrigan, Frances
Cernak, Ibolja
McAteer, Kelly
Hellewell, Sarah C.
Rosenfeld, Jeffrey V.
Turner, Renée J.
Vink, Robert
Article History
Received: 20 July 2020
Accepted: 5 April 2021
First Online: 23 April 2021
Competing interests
: RV is the named inventor on a filed patent (PCT/AU2014/050108) describing the use of NK1 antagonists in CTE. All other authors declare no competing interests.